Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 19, Issue 7, Pages 1059-1066Publisher
WILEY
DOI: 10.1359/JBMR.040305
Keywords
RANKL; osteoprotegerin; osteoporosis; bone resorption; AMG 162
Categories
Ask authors/readers for more resources
The safety and bone antiresorptive effect of a single subcutaneous dose of AMG 162, a human monoclonal antibody to RANKL, was investigated in 49 postmenopausal women. AMG 162 is a potent antiresorptive agent for diseases such as osteoporosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
